Clinical Trial Update: A Study in Healthy Volunteers of Single Doses of Orally Administered Investigational Product to Investigate Safety, Tolerability, and Pharmacokinecs. [Phase 1]

View source ↗

Summary

Phase 1 study in healthy volunteers assessing safety, tolerability, and pharmacokinetics after a single oral dose of an investigational product for dyslipidemia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia

Snippet

Sponsor: GlaxoSmithKline | Conditions: Dyslipidaemias | Phase 1 | Status: COMPLETED